Abstract: Pancreatic ductal adenocarcinoma (PDAC) is one of the most lethal cancers, with lymph node metastasis (LNM) being a critical determinant in patient prognosis and therapeutic planning [1-2]. Conventional methods for detecting LNM in PDAC primarily rely on contrast-enhanced CT scans, but these often fall short in sensitivity, especially in early-stage disease.